| Kiran Prabhu, MD | |
|
5901 W Memorial Rd, Oklahoma City, OK 73142-2015 | |
| (405) 369-7819 | |
| Not Available |
| Full Name | Kiran Prabhu |
|---|---|
| Gender | Female |
| Speciality | Radiation Oncology |
| Experience | 38 Years |
| Location | 5901 W Memorial Rd, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457393894 | NPI | - | NPPES |
| 100132270B | Medicaid | OK | |
| P00742422 | Other | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | 16531 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Integris Baptist Medical Center, Inc | Oklahoma city, OK | Hospital |
| Integris Bass Baptist Health Center | Enid, OK | Hospital |
| Integris Southwest Medical Center | Oklahoma city, OK | Hospital |
| St Mary's Regional Medical Center | Enid, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oklahoma Proton Center Llc | 4183963861 | 14 |
| Radiation Medicine Associates, P.c. | 6507756137 | 7 |
News Archive
Catalyst Rx, the pharmacy benefit management (PBM) subsidiary of Catalyst Health Solutions, Inc., announced the award of a new service contract with Wellmark following a competitive bid process. Wellmark does business as Wellmark Blue Cross and Blue Shield of Iowa and its subsidiaries include Wellmark Blue Cross and Blue Shield of South Dakota and Wellmark Health Plan of Iowa, Inc. Wellmark Blue Cross and Blue Shield is an independent licensee of the Blue Cross and Blue Shield Association.
The final results of the Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) demonstrate that COVID-19 convalescent plasma did not prevent disease progression in a high-risk group of outpatients with COVID-19, when administered within the first week of their symptoms.
Scientists at Saint Louis University are preparing for the potential pandemic spread of a new bird flu strain that caused severe disease in China last spring, joining researchers from seven other Vaccine and Treatment Evaluation Units funded by the National Institutes of Health (NIH) to test vaccines to protect against the illness in adults.
Politico reports on how immigration status will play into this effort, and McClatchy notes the strain that will be felt by the physician workforce as a result of the across-the-board push to increase access to care.
› Verified 6 days ago
| Entity Name | Comprehensive Cancer Center Of Oklahoma Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831272889 PECOS PAC ID: 3476457227 Enrollment ID: O20031122000083 |
News Archive
Catalyst Rx, the pharmacy benefit management (PBM) subsidiary of Catalyst Health Solutions, Inc., announced the award of a new service contract with Wellmark following a competitive bid process. Wellmark does business as Wellmark Blue Cross and Blue Shield of Iowa and its subsidiaries include Wellmark Blue Cross and Blue Shield of South Dakota and Wellmark Health Plan of Iowa, Inc. Wellmark Blue Cross and Blue Shield is an independent licensee of the Blue Cross and Blue Shield Association.
The final results of the Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) demonstrate that COVID-19 convalescent plasma did not prevent disease progression in a high-risk group of outpatients with COVID-19, when administered within the first week of their symptoms.
Scientists at Saint Louis University are preparing for the potential pandemic spread of a new bird flu strain that caused severe disease in China last spring, joining researchers from seven other Vaccine and Treatment Evaluation Units funded by the National Institutes of Health (NIH) to test vaccines to protect against the illness in adults.
Politico reports on how immigration status will play into this effort, and McClatchy notes the strain that will be felt by the physician workforce as a result of the across-the-board push to increase access to care.
› Verified 6 days ago
| Entity Name | Radiation Medicine Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679631329 PECOS PAC ID: 6507756137 Enrollment ID: O20040317001387 |
News Archive
Catalyst Rx, the pharmacy benefit management (PBM) subsidiary of Catalyst Health Solutions, Inc., announced the award of a new service contract with Wellmark following a competitive bid process. Wellmark does business as Wellmark Blue Cross and Blue Shield of Iowa and its subsidiaries include Wellmark Blue Cross and Blue Shield of South Dakota and Wellmark Health Plan of Iowa, Inc. Wellmark Blue Cross and Blue Shield is an independent licensee of the Blue Cross and Blue Shield Association.
The final results of the Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) demonstrate that COVID-19 convalescent plasma did not prevent disease progression in a high-risk group of outpatients with COVID-19, when administered within the first week of their symptoms.
Scientists at Saint Louis University are preparing for the potential pandemic spread of a new bird flu strain that caused severe disease in China last spring, joining researchers from seven other Vaccine and Treatment Evaluation Units funded by the National Institutes of Health (NIH) to test vaccines to protect against the illness in adults.
Politico reports on how immigration status will play into this effort, and McClatchy notes the strain that will be felt by the physician workforce as a result of the across-the-board push to increase access to care.
› Verified 6 days ago
| Entity Name | Oklahoma Proton Center Llc |
|---|---|
| Entity Type | Part B Supplier - Radiation Therapy Center |
| Entity Identifiers | NPI Number: 1114408762 PECOS PAC ID: 4183963861 Enrollment ID: O20190225000069 |
News Archive
Catalyst Rx, the pharmacy benefit management (PBM) subsidiary of Catalyst Health Solutions, Inc., announced the award of a new service contract with Wellmark following a competitive bid process. Wellmark does business as Wellmark Blue Cross and Blue Shield of Iowa and its subsidiaries include Wellmark Blue Cross and Blue Shield of South Dakota and Wellmark Health Plan of Iowa, Inc. Wellmark Blue Cross and Blue Shield is an independent licensee of the Blue Cross and Blue Shield Association.
The final results of the Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) demonstrate that COVID-19 convalescent plasma did not prevent disease progression in a high-risk group of outpatients with COVID-19, when administered within the first week of their symptoms.
Scientists at Saint Louis University are preparing for the potential pandemic spread of a new bird flu strain that caused severe disease in China last spring, joining researchers from seven other Vaccine and Treatment Evaluation Units funded by the National Institutes of Health (NIH) to test vaccines to protect against the illness in adults.
Politico reports on how immigration status will play into this effort, and McClatchy notes the strain that will be felt by the physician workforce as a result of the across-the-board push to increase access to care.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kiran Prabhu, MD Po Box 248856, Oklahoma City, OK 73124-8856 Ph: (405) 607-4520 | Kiran Prabhu, MD 5901 W Memorial Rd, Oklahoma City, OK 73142-2015 Ph: (405) 369-7819 |
News Archive
Catalyst Rx, the pharmacy benefit management (PBM) subsidiary of Catalyst Health Solutions, Inc., announced the award of a new service contract with Wellmark following a competitive bid process. Wellmark does business as Wellmark Blue Cross and Blue Shield of Iowa and its subsidiaries include Wellmark Blue Cross and Blue Shield of South Dakota and Wellmark Health Plan of Iowa, Inc. Wellmark Blue Cross and Blue Shield is an independent licensee of the Blue Cross and Blue Shield Association.
The final results of the Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) demonstrate that COVID-19 convalescent plasma did not prevent disease progression in a high-risk group of outpatients with COVID-19, when administered within the first week of their symptoms.
Scientists at Saint Louis University are preparing for the potential pandemic spread of a new bird flu strain that caused severe disease in China last spring, joining researchers from seven other Vaccine and Treatment Evaluation Units funded by the National Institutes of Health (NIH) to test vaccines to protect against the illness in adults.
Politico reports on how immigration status will play into this effort, and McClatchy notes the strain that will be felt by the physician workforce as a result of the across-the-board push to increase access to care.
› Verified 6 days ago
Dr. Jennifer Kathleen Hinkle, MD Radiology Medicare: Medicare Enrolled Practice Location: 921 Ne 13th St, Oklahoma City, OK 73104 Phone: 405-456-2589 | |
Dr. Bryan Lee Vanzandt, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4625 S Western Ave, Oklahoma City, OK 73109 Phone: 405-632-2323 Fax: 405-631-9315 | |
Charles Eric Eckman, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 14101 Parkway Commons, Oklahoma City, OK 73134 Phone: 405-749-6277 | |
Robert K Gelczer, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3433 Nw 56th St., Suite C-40, Oklahoma City, OK 73112 Phone: 405-945-4741 Fax: 888-972-5320 | |
Vikas Vij, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3433 Nw 56th St, Suite C-40, Oklahoma City, OK 73112 Phone: 405-945-4741 Fax: 888-972-5320 | |
William G Phillips, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2224 Nw 50th St, Suite 276w, Oklahoma City, OK 73112 Phone: 405-858-2350 | |
Ronald Ray Magee, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5224 E I 240 Service Rd Ste 303, Oklahoma City, OK 73135 Phone: 405-608-3800 Fax: 405-628-6477 |